BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Randox Launch New High Sensitivity Troponin T Control with Ultra Low Target Values


10/12/2011 6:58:59 AM

Crumlin, UK, October 12, 2011 / B3C newswire / – Randox Laboratories the international clinical diagnostics company announce the launch of a new high sensitivity troponin T control. The new control allows clinical laboratories to more accurately monitor and assess the performance of their hsTnT (High Sensitivity Troponin T) assay.

Cardiac Troponins are widely used in the detection of Myocardial Infarction (MI) with even small elevations in the levels of cardiac troponin indicating damage to the heart and possible MI. In light of this both the European Society of Cardiology (ESC) and the American College of Cardiology (ACC) recommend the use of a highly sensitive troponin assay with excellent precision (less than 10% CV) at the 99th percentile of the reference range.

Before now, suitable control materials for high sensitivity Troponin T with target values sufficiently close to the 99th percentile of the reference range (14ng/L) were unavailable. The recent launch of the Randox Acusera High Sensitivity Troponin T Control has changed things and now provides laboratories with the ability to more accurately monitor and assess the performance of their hsTnT assay.

The ultra low Troponin T levels found in the Randox control are significantly lower than those found in other manufacturers QC material. Target values for the Randox control are generally around 16.5ng/l (range 12.4 – 20.6ng/l) and are closest to the 14ng/ml cut off.

The Acusera high sensitivity troponin T control has a shelf life of up to 4 years meaning the same lot of control material can be used for longer thus reducing the problems associated with lot crossovers. A reconstituted stability of 5 days at +2 - +8oC or 4 weeks at -20oC minimises unnecessary waste and provides significant cost savings.

Randox also manufacture a liquid cardiac control with assayed values for an impressive 10 cardiac markers including BNP, CK-MB, D-dimer, Digoxin, Homocysteine, hsCRP, Myoglobin, NT-ProBNP, Troponin I and Troponin T. As the name suggests the control is liquid ready to use for added convenience and ease of us. Three levels are available spanning the complete clinical range with cut off levels for both Troponin I and T in line with international recommendations.

About Randox

Headquartered in the United Kingdom, Randox Laboratories Ltd. is a market leader within the in vitro diagnostics industry, manufacturing high quality diagnostic products for laboratories worldwide. Our extensive product portfolio offers complete solutions within the fields of clinical chemistry, cardiology, forensic toxicology, veterinary, drug residues, life sciences, oncology, molecular diagnostics and internal and external quality control. Our goal is to ‘revolutionise healthcare through continuously improving diagnostic solutions.’ We continue to achieve this year after year due to our commitment and significant re-investment in Research and Development. Our innovative approach to diagnostics allows us to develop revolutionary products, specifically designed to provide more efficient, higher quality and reliable results, ensuring patients receive the right diagnosis at the right time.

For further information contact us at marketing@randox.com



Read at BioSpace.com

Randox
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->